Search
Add Trial
Sign In

Checkmate 816 – CA209-816 - Hosted By

0

Randomized, Open Label, Phase 3 trial of Nivolumab Plus Ipilimumab or Nivolumab Plus Platinum Doublet Chemotherapy vs Platinum Doublet Chemotherapy in early stage Non-Small Cell Lung Cancer

Study Type Treatment
Sponsor Name BMS
Disease type Non-Small Cell Lung Cancer
Disease Stage I-III
Clinical Status Neoadjuvant
Phase III
Intervention / Treatment Nivolumab + Ipilimumab vs Nivolumab + Chemotherapy vs Chemotherapy alone
Research Site CISSS de l’Outaouais – Gatineau Hospital
Investigator Dr Shelly Sud
Coordinator Mai Le
Telephone number
Fax number
Study start date January 13, 2017
Study end date
Trial Status Recruiting
Study Type Treatment
Sponsor Name
Tumor Site NSCLC - Non Small Cell Lung Cancer
Disease Stage Stage I, Stage II, Stage III
Clinical Status Neo-Adjuvant, Operable
Phase Phase I
Intervention / Treatment
Research Site CISSS de l'Outaouais - Gatineau Hospital
Investigator
Coordinator
Telephone Number +1 (819) 966-6000
Fax Number
Study Start Date
Study End Date
Trial Status

Tags

Working Hours :

Now Closed UTC - 4
  • MondayDay Off
  • TuesdayDay Off
  • WednesdayDay Off
  • ThursdayDay Off
  • FridayDay Off
  • SaturdayDay Off
  • SundayDay Off

Price / Claim :

Recruit a patient:

*for confidentiality, do not include the name of the patient

*pour raisons de confidentialité, n'incluez pas le nom du patient

Hosted by :

Claim listing: Checkmate 816 – CA209-816

Our website is under development. We're sorry for any inconvenience that might appear.Notre site web est en cours de développement. Nous sommes désolés pour tout inconvénient qui pourrait survenir.

Reply to Message

Sign In KANCEL

Account details will be confirmed via email.

Reset Your Password